Yakira Capital Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,070	Closed	-$2.53M	–	434
2021 Q3	$2.53M	Hold	25,070	–	–	0.39%	78
2021 Q2	$2.5M	Buy	+25,070	New	+$2.5M	0.41%	62